CN101569673A - Chinese medicinal preparation for treating female sterility caused by salpingemphraxis - Google Patents

Chinese medicinal preparation for treating female sterility caused by salpingemphraxis Download PDF

Info

Publication number
CN101569673A
CN101569673A CNA2009100652042A CN200910065204A CN101569673A CN 101569673 A CN101569673 A CN 101569673A CN A2009100652042 A CNA2009100652042 A CN A2009100652042A CN 200910065204 A CN200910065204 A CN 200910065204A CN 101569673 A CN101569673 A CN 101569673A
Authority
CN
China
Prior art keywords
salpingemphraxis
fructus
treatment
weight portion
following weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2009100652042A
Other languages
Chinese (zh)
Other versions
CN101569673B (en
Inventor
樊成华
樊璠
秦岭
秦恒
李翊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009100652042A priority Critical patent/CN101569673B/en
Publication of CN101569673A publication Critical patent/CN101569673A/en
Application granted granted Critical
Publication of CN101569673B publication Critical patent/CN101569673B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a preparation for treating female sterility, in particular to a Chinese medicinal preparation for treating female sterility caused by salpingemphraxis. The Chinese medicinal preparation mainly adopts Chinese medicines by certain weight portion, such as pangolin, pseudo-ginseng, frankincense, safflower, hemlock parsley, peach kernel, rhizoma zedoariae and the like, to play the functions of sterilizing and diminishing inflammation, eliminating stasis to resolve swelling, circulating blood and dissipating stagnation, regulating the menstruation and dispersing ruffian, removing retention and circulating vital energy, dredging and lubricating the intestines on salpinx chronic inflammation, conglutination, hydrops and obstructive obstruction. Compared with the traditional treatment method, the Chinese medicinal prepration has the advantages of treating both principal and secondary aspect of disease without any pain or side effect on a patient with accurate healing efficacy on clinical tests, and significantly improving the cure rate and pregnancy rate after healing.

Description

A kind ofly treat the Chinese medicine preparation that salpingemphraxis causes female acyesis
Technical field
The invention belongs to tcm field, relate to the medicament for the treatment of woman's acyesis, be specifically related to a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of.
Background technology
The reason that causes woman infertility is many-sided, wherein accounts for about 40% of whole infertile patient because of women's salpingemphraxis causes infertile patient.Cause the reason of women's salpingemphraxis mainly contain following some: women's intrauterine adhesion, fallopian tube adhesion are one of common causes that causes women's salpingemphraxis, and how due to illness the originality antibacterial is invaded and infects, repeatedly dilatation and curettage, inner film injury is serious; Uterine tube stegnosis due to the fallopian tube chronic inflammatory disease, fallopian tube tumor blocks or spasm; The hydrosalpinx distortion; Also has congenital obstruction of fallopian tube.In a single day fallopian tube blocks, and germ cell can't enter the uterus and become pregnant; As in fallopian tube, becoming pregnant, then can cause dangerous ectopic pregnancy.
Traditional fallopian tube dredging method is as hydrotubation, though certain effect is arranged, but the pressure that obtains at logical liquid art median oviduct is little, and the treatment medicinal liquid is difficult to enter, and can't determine fallopian tube be one-sided or bilateral obstructed, blindness is big, and cure rate and pregnancy rate are lower, and about about 15%.
Hysteroscope is comparatively advanced at present Minimally Invasive Surgery, direct-view is visible uterine cavity and fallopian tube open condition down, and can understand lesion degree, can get rid of polyp and adhesion that inflammation causes, but because of conduit in the art inserts matter portion between fallopian tube, only the nearly section in an angle, palace and a matter portion has been blocked direct mediation effect, far-end is difficult to relate to; Moreover because the 26S Proteasome Structure and Function that serious inflammation causes fallopian tube destroys and can't reverse, and peritubal adhesion still can't remove through the logical liquid of hysteroscope intubate, not only cure rate is lower, and can cause the ectopic pregnancy rate to increase on the contrary.
Summary of the invention
The inventor is in the diagnosis and treatment activity of being engaged in gynaecopathia for many years, through investigation, the method of finding the infertility that traditional western medical treatment salpingemphraxis causes exists open defect, people thirst for the medicine of definite curative effect treatment women salpingemphraxis, treat the report that salpingemphraxis causes the Chinese medicine medicine of female acyesis and also find no pass the present invention at present.
The objective of the invention is to study a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of, can better overcome the existing defective of existing treatment similar disease method.
Be to realize task of the present invention, the inventor is through exploring repeatedly, and test improves, and the technical scheme of being taked is to propose a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of, and adopts following weight portion material medicine, as basic prescription:
Squama Manis 5-30, Radix Notoginseng 5-25, Olibanum 5-25, Myrrha 5-25, Radix Salviae Miltiorrhizae 10-40, Fructus Liquidambaris 5-25, Flos Carthami 5-25, Flos Lonicerae 5-30, Herba Taraxaci 10-40, Fructus Forsythiae 10-40, Fructus Crataegi 10-40, Rhizoma Chuanxiong 5-25, Radix Angelicae Sinensis 10-40.
Said medicine and component sum up out in exploratory experiment repeatedly through the inventor, all have curative effect preferably in each component drug dose scope.
Through optimizing, a kind of salpingemphraxis for the treatment of of the present invention causes that the Chinese medicine preparation of female acyesis adopts following weight portion material medicine prescription to the inventor to above-mentioned prescription:
Squama Manis 10-25, Radix Notoginseng 10-20, Olibanum 10-20, Myrrha 10-20, Radix Salviae Miltiorrhizae 15-35, Fructus Liquidambaris 10-20, Flos Carthami 10-20, Flos Lonicerae 10-25, Herba Taraxaci 15-35, Fructus Forsythiae 15-35, Fructus Crataegi 15-35, Rhizoma Chuanxiong 10-20, Radix Angelicae Sinensis 15-35.
In order further to improve curative effect, make fallopian tube more unobstructed, exist the serious difficult state of an illness of salpingemphraxis at the part patient, the inventor explores through a large amount of tests, also adds following weight portion material medicine in above-mentioned prescription, as the potentiation prescription:
Semen Persicae 5-25, Fructus Aurantii Immaturus 5-25, rhizoma sparganic 5-25, Rhizoma Curcumae 5-25.
Through preferred, institute adds the material medicine weight portion and is:
Semen Persicae 10-20, Fructus Aurantii Immaturus 10-20, rhizoma sparganic 10-20, Rhizoma Curcumae 10-20.
The present invention is directed to women's salpingemphraxis and mainly produce reason, comprehensive dialectical prescription, the selection Squama Manis is a monarch drug, because: Squama Manis, nature and flavor are salty to be slightly cold, and returns liver, stomach warp, the tool stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, expel wind to dredge collateral effect;
Select Radix Notoginseng, Olibanum, Myrrha, Radix Salviae Miltiorrhizae, Fructus Liquidambaris are ministerial drug, because: Radix Notoginseng, sweet, the little hardship of nature and flavor, temperature is returned liver, kidney channel, the hemostasis of tool dissipating blood stasis, subduing swelling and relieving pain effect; Olibanum, nature and flavor suffering, hardship, temperature, GUIXIN, spleen, Liver Channel, tool promoting blood circulation and stopping pain, detumescence effect; Myrrha, the nature and flavor hardship, flat, GUIXIN, spleen, Liver Channel, tool eliminating stasis to stop pain, detumescence effect; Radix Salviae Miltiorrhizae, the nature and flavor hardship is slightly cold, GUIXIN, Liver Channel, tool stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow effect; Fructus Liquidambaris, the nature and flavor hardship, flat, current 12 warps, the effect of stimulating the menstrual flow of tool dispelling, collateral-activating, diuretic;
Select Flos Carthami, Flos Lonicerae, Herba Taraxaci, Fructus Forsythiae, Fructus Crataegi is an adjuvant drug, because: Flos Carthami, nature and flavor suffering, temperature, GUIXIN, Liver Channel, tool promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain effect; Flos Lonicerae, nature and flavor are sweet, and are cold, return lung, the heart, stomach warp, tool heat-clearing and toxic substances removing, wind-heat dissipating effect; Herba Taraxaci, nature and flavor hardship, sweet, cold, return liver, stomach warp, tool heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, diuresis inducing function; Fructus Forsythiae, the nature and flavor hardship is slightly cold, and returns lung, the heart, gallbladder meridian, tool heat-clearing and toxic substances removing, mass dissipating and swelling eliminating effect; Fructus Crataegi, nature and flavor acid is sweet, and tepor is returned spleen, stomach, Liver Channel, tool promoting digestion and invigorating the stomach, the effect of circulation of qi promoting dissipating blood stasis;
Select Rhizoma Chuanxiong, when being classified as messenger drug, because: Rhizoma Chuanxiong, the nature and flavor suffering, temperature is returned liver, gallbladder, pericardium channel, tool blood-activating and qi-promoting, wind-expelling pain-stopping effect; Radix Angelicae Sinensis, nature and flavor are sweet, hot, and temperature is returned liver, the heart, spleen channel, and tool is enriched blood and is invigorated blood circulation, menstruction regulating and pain relieving, functions of loosening bowel relieving constipation;
In the side of increasing of said medicine prescription, because: Semen Persicae, the nature and flavor hardship, flat, GUIXIN, liver, kidney, large intestine channel, tool activating blood circulation and dissipating phlegm, functions of loosening bowel relieving constipation; Fructus Aurantii Immaturus, the nature and flavor hardship, cold, return spleen, stomach warp, tool dispelling the stagnated QI removing food stagnancy, the painful abdominal mass effect of loosing of reducing phlegm; Rhizoma sparganic, nature and flavor suffering, hardship, flat, return liver, spleen channel, the circulation of qi promoting of tool removing blood stasis, removing food stagnancy analgesic effect; Rhizoma Curcumae, nature and flavor suffering, hardship, temperature,, return liver, spleen channel, tool circulation of qi promoting removing blood stasis, removing food stagnancy analgesic effect.Institute increases the collaborative monarch of medicine, all medicines of minister, more can bring into play effect, improves the curative effect that difficulty is blocked.
The said medicine composition of prescription, each effect synergism utilizes tcm treatment according to syndrome differentiation, can not only be to the fallopian tube chronic inflammatory disease, intrauterine adhesion, wound plays bactericidal antiphlogistic, dissipating blood stasis for subsidence of swelling, active eliminating stagnation, regulating menstruation is stimulated the menstrual flow, the effect of mediation tube chamber, and can also hydrosalpinx be blocked and play removing food stagnancy, the removing blood stasis circulation of qi promoting, the logical thin smooth function of profit is compared with traditional treatment salpingemphraxis method, has treating both the principal and secondary aspects of a disease, reduce patient's misery, have no side effect, more effective treatment salpingemphraxis is accomplished determined curative effect, fallopian tube is unimpeded, cure rate, cure advantages such as the back pregnancy rate significantly improves.
The specific embodiment
The present invention is a kind of to treat the Example formulations 1 that salpingemphraxis causes the Chinese medicine preparation of female acyesis, adopts following weight portion material medicine:
Squama Manis 5, Radix Notoginseng 5, Olibanum 5, Myrrha 5, Radix Salviae Miltiorrhizae 10, Fructus Liquidambaris 5, Flos Carthami 5, Flos Lonicerae 5, Herba Taraxaci 10, Fructus Forsythiae 10, Fructus Crataegi 10, Rhizoma Chuanxiong 5, Radix Angelicae Sinensis 10.
The present invention is a kind of to treat the Example formulations 2 that salpingemphraxis causes the Chinese medicine preparation of female acyesis, adopts following weight portion material medicine:
Squama Manis 30, Radix Notoginseng 25, Olibanum 25, Myrrha 25, Radix Salviae Miltiorrhizae 40, Fructus Liquidambaris 25, Flos Carthami 25, Flos Lonicerae 30, Herba Taraxaci 40, Fructus Forsythiae 40, Fructus Crataegi 40, Rhizoma Chuanxiong 25, Radix Angelicae Sinensis 40.
The present invention is a kind of to treat the Example formulations 3 that salpingemphraxis causes the Chinese medicine preparation of female acyesis, adopts following weight portion material medicine:
Squama Manis 15, Radix Notoginseng 15, Olibanum 15, Myrrha 15, Radix Salviae Miltiorrhizae 20, Fructus Liquidambaris 15, Flos Carthami 15, Flos Lonicerae 20, Herba Taraxaci 20, Fructus Forsythiae 25, Fructus Crataegi 25, Rhizoma Chuanxiong 15, Radix Angelicae Sinensis 20.
The present invention is a kind of to treat the Example formulations 4 that salpingemphraxis causes the Chinese medicine preparation of female acyesis, adopts in embodiment 1 prescription, also adds following weight portion material medicine:
Semen Persicae 5, Fructus Aurantii Immaturus 5, rhizoma sparganic 5, Rhizoma Curcumae 5.
The present invention is a kind of to treat the Example formulations 5 that salpingemphraxis causes the Chinese medicine preparation of female acyesis, adopts in embodiment 2 prescriptions, also adds following weight portion material medicine:
Semen Persicae 25, Fructus Aurantii Immaturus 25, rhizoma sparganic 25, Rhizoma Curcumae 25.
The present invention is a kind of to treat the Example formulations 6 that salpingemphraxis causes the Chinese medicine preparation of female acyesis, adopts in embodiment 3 prescriptions, also adds following weight portion material medicine:
Semen Persicae 15, Fructus Aurantii Immaturus 15, rhizoma sparganic 15, Rhizoma Curcumae 15.
Take by weighing according to the said medicine weight proportion, mix, pulverize, sieve, preparation method is made capsule formulation or pill-type routinely.
Function and therapeutic domain: cure mainly women's uterine cavity, fallopian tube adhesion and chronic inflammatory disease, fallopian tube tumor, hydrosalpinx, obstruction of fallopian tube.
Usage and dosage: 3 times on the 1st, each 9-10 gram, ante cibum warm water delivery service, 1 month was 1 course of treatment, the shortest 1 course of treatment, the longest 6 courses of treatment.Period in a medicine diet irritable food is noted the sexual life health.
Clinical observation material: under the voluntary condition of patient, random experiment is totally 315 examples, wherein 20 years old-25 years old 69 examples, 26 years old-30 years old 88 examples, 31 years old-35 years old 113 examples, 36 years old-45 years old 45 examples; Chronic salpingitis 123 examples, uterine cavity, fallopian tube adhesion 104 examples, hydrosalpinx 62 examples, fallopian tube tumor 18 examples, obstruction of fallopian tube 8 examples; The course of disease is the shortest 2 years, and is the longest 10 years.Wherein 158 examples belonged to once outer tame hospital and make a definite diagnosis and fail to respond to any medical treatment by traditional method, and its age, routine number, the state of an illness have comparability, and the present invention compares with this, and continues to participate in the experimental observation treatment.
Diagnostic criteria:
The logical liquid angiographic diagnosis of utilization or referring to making a definite diagnosis conclusion: the fallopian tube bilateral is obstructed, hydrosalpinx, obstruction of fallopian tube.
Therapeutic Method:
1. to 315 example test patients, all obey the basic prescription medicament of the present invention, 3 times on the 1st, each 9 grams, every 1 gram, ante cibum warm water delivery service, one month is 1 course of treatment, the shortest 1 course of treatment, the longest 5 courses of treatment.Period in a medicine diet irritable food, sexual life is noted the health cleaning.
2. to through 5 course of therapy DeGrains, or effective but not smooth patient continues to treat 1 course of treatment, all obeys potentiation prescription medicament of the present invention, 3 times on the 1st, each 10 grams, ante cibum warm water delivery service.
Efficacy assessment standard:
Criterion of cure is that the bilateral fallopian tube is unimpeded; Though effectively standard is not for logical smooth; Invalid (little effect) standard is obstructed or logical slightly.
Result and analysis:
The patient is controlled in 315 example examinations, controls observation through 1-6 the examination course of treatment, cures 142 examples, cure rate 45.4%, effective 94 examples, effective percentage 30.3%, invalid (little effect) 79 examples, total effective rate 75.7%, the patient who possesses the ability of breeding cures after feedback and visit basic all conceived.
Model case: several examples of summary from preserve case prove that the present invention causes the definite effect of female acyesis at treatment women salpingemphraxis.
Case 1, king XX, the woman, 37 years old, the worker of Beijing, Nanyang main road water conservancy bureau made a definite diagnosis through outer tame hospital and to suffer from Secondary cases fallopian tube bilateral and block, it is invalid more than 7 years treat, through taking medicament of the present invention, 5 the course of treatment produce effects, continuous with fully recovering 1 course of treatment, no longer give birth to.
Case 2, grandson XX, the woman, 30 years old, Nanyang seven Li Yuan people from street suffered from constitutional fallopian tube bilateral and block, and 5 years unpregnancies are through taking medicament of the present invention, 5 the recovery from illness back pregnancies course of treatment.
Case 3, Nie XX, the woman, 21 years old, Dengzhou City, Henan Province people from Dongcheng District suffered from congenital obstruction of fallopian tube, through taking medicament of the present invention, 5 the course of treatment produce effects, 1 recovery from illness course of treatment of clothes continues.
Case 4, king XX, the woman, 26 years old, the Nanyang bank clerk suffered from hydrosalpinx, cured 1 course of treatment through taking medicament of the present invention.The back is conceived.
Case 5, Lee XX, the woman, 35 years old, the worker of Nanyang company suffered from adnexitis and causes fallopian tube adhesion, and through taking medicament of the present invention, cure 3 courses of treatment.

Claims (10)

1, a kind ofly treat the Chinese medicine preparation that salpingemphraxis causes female acyesis, it is characterized in that adopting following weight portion material medicine:
Squama Manis 5-30, Radix Notoginseng 5-25, Olibanum 5-25, Myrrha 5-25, Radix Salviae Miltiorrhizae 10-40, Fructus Liquidambaris 5-25, Flos Carthami 5-25, Flos Lonicerae 5-30, Herba Taraxaci 10-40, Fructus Forsythiae 10-40, Fructus Crataegi 10-40, Rhizoma Chuanxiong 5-25, Radix Angelicae Sinensis 10-40.
2, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 1 is characterized in that also adding following weight portion material medicine in described medicine:
Semen Persicae 5-25, Fructus Aurantii Immaturus 5-25, rhizoma sparganic 5-25, Rhizoma Curcumae 5-25.
3, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 1 is characterized in that adopting following weight portion material medicine:
Squama Manis 10-25, Radix Notoginseng 10-20, Olibanum 10-20, Myrrha 10-20, Radix Salviae Miltiorrhizae 15-35, Fructus Liquidambaris 10-20, Flos Carthami 10-20, Flos Lonicerae 10-25, Herba Taraxaci 15-35, Fructus Forsythiae 15-35, Fructus Crataegi 15-35, Rhizoma Chuanxiong 10-20, Radix Angelicae Sinensis 15-35.
4, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 3 is characterized in that also adding following weight portion material medicine in described medicine:
Semen Persicae 10-20, Fructus Aurantii Immaturus 10-20, rhizoma sparganic 10-20, Rhizoma Curcumae 10-20.
5, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 1 is characterized in that adopting following weight portion material medicine:
Squama Manis 5, Radix Notoginseng 5, Olibanum 5, Myrrha 5, Radix Salviae Miltiorrhizae 10, Fructus Liquidambaris 5, Flos Carthami 5, Flos Lonicerae 5, Herba Taraxaci 10, Fructus Forsythiae 10, Fructus Crataegi 10, Rhizoma Chuanxiong 5, Radix Angelicae Sinensis 10.
6, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 1 is characterized in that adopting following weight portion material medicine:
Squama Manis 30, Radix Notoginseng 25, Olibanum 25, Myrrha 25, Radix Salviae Miltiorrhizae 40, Fructus Liquidambaris 25, Flos Carthami 25, Flos Lonicerae 30, Herba Taraxaci 40, Fructus Forsythiae 40, Fructus Crataegi 40, Rhizoma Chuanxiong 25, Radix Angelicae Sinensis 40.
7, treat the Chinese medicine preparation that salpingemphraxis causes female acyesis as claim 1 or 3 a kind of, it is characterized in that adopting following weight portion material medicine:
Squama Manis 15, Radix Notoginseng 15, Olibanum 15, Myrrha 15, Radix Salviae Miltiorrhizae 20, Fructus Liquidambaris 15, Flos Carthami 15, Flos Lonicerae 20, Herba Taraxaci 20, Fructus Forsythiae 25, Fructus Crataegi 25, Rhizoma Chuanxiong 15, Radix Angelicae Sinensis 20.
8, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 5 is characterized in that also adding following weight portion material medicine in described medicine:
Semen Persicae 5, Fructus Aurantii Immaturus 5, rhizoma sparganic 5, Rhizoma Curcumae 5.
9, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 6 is characterized in that also adding following weight portion material medicine in described medicine:
Semen Persicae 25, Fructus Aurantii Immaturus 25, rhizoma sparganic 25, Rhizoma Curcumae 25.
10, a kind of Chinese medicine preparation that salpingemphraxis causes female acyesis for the treatment of as claimed in claim 7 is characterized in that also adding following weight portion material medicine in described medicine:
Semen Persicae 15, Fructus Aurantii Immaturus 15, rhizoma sparganic 15, Rhizoma Curcumae 15.
CN2009100652042A 2009-06-10 2009-06-10 Chinese medicinal preparation for treating female sterility caused by salpingemphraxis Active CN101569673B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100652042A CN101569673B (en) 2009-06-10 2009-06-10 Chinese medicinal preparation for treating female sterility caused by salpingemphraxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100652042A CN101569673B (en) 2009-06-10 2009-06-10 Chinese medicinal preparation for treating female sterility caused by salpingemphraxis

Publications (2)

Publication Number Publication Date
CN101569673A true CN101569673A (en) 2009-11-04
CN101569673B CN101569673B (en) 2011-03-23

Family

ID=41229243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100652042A Active CN101569673B (en) 2009-06-10 2009-06-10 Chinese medicinal preparation for treating female sterility caused by salpingemphraxis

Country Status (1)

Country Link
CN (1) CN101569673B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101972317A (en) * 2010-10-14 2011-02-16 胡心德 Medicament for treating fallopian tube obstructive infertility
CN102908434A (en) * 2012-11-01 2013-02-06 蔡瑞满 Chinese medicinal composition for dredging female uterine tubes
CN102940814A (en) * 2012-11-26 2013-02-27 葛才志 Medicine for treating tubal nowhere
CN102949623A (en) * 2012-10-27 2013-03-06 左权县蓝天中药科技开发有限公司 Medicine for treating hydrosalpinx
CN103156943A (en) * 2013-03-25 2013-06-19 薛洪喜 Medicament for treating infertility of obstructive uterine tube
CN103893654A (en) * 2014-03-30 2014-07-02 赵玉红 Traditional Chinese medicine external plaster for treating salpinx obstructive infertility and nursing method thereof
CN103893340A (en) * 2014-03-26 2014-07-02 王景美 Traditional Chinese medicine preparation for treating cold coagulation and blood stasis type oviduct obstructive infertility
CN103990076A (en) * 2014-06-04 2014-08-20 河北省中医药研究院 Traditional Chinese medicine composition for treating female infertility and preparation and preparation method of composition
CN110292620A (en) * 2018-03-23 2019-10-01 李同春 The method of the Chinese medicine composition and preparation for the treatment of cancer and application and treating cancer
CN111643638A (en) * 2020-07-02 2020-09-11 贾锐 A method for treating infertility by compound therapy of traditional Chinese medicine
CN115737771A (en) * 2022-12-19 2023-03-07 广东罗浮山国药股份有限公司 Traditional Chinese medicine composition for treating liver qi stagnation type salpingemphraxis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100546617C (en) * 2006-10-19 2009-10-07 北京万寿通医药科技有限公司 A kind of Chinese medicine preparation for the treatment of oviduct obstructive sterility

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101972317A (en) * 2010-10-14 2011-02-16 胡心德 Medicament for treating fallopian tube obstructive infertility
CN102949623A (en) * 2012-10-27 2013-03-06 左权县蓝天中药科技开发有限公司 Medicine for treating hydrosalpinx
CN102949623B (en) * 2012-10-27 2015-12-16 左权县蓝天中药科技开发有限公司 The medicine for the treatment of hydrosalpinx
CN102908434A (en) * 2012-11-01 2013-02-06 蔡瑞满 Chinese medicinal composition for dredging female uterine tubes
CN102908434B (en) * 2012-11-01 2014-06-25 蔡瑞满 Chinese medicinal composition for dredging female uterine tubes
CN102940814A (en) * 2012-11-26 2013-02-27 葛才志 Medicine for treating tubal nowhere
CN102940814B (en) * 2012-11-26 2013-12-25 济南宏坤大药房 Medicine for treating tubal nowhere
CN103156943B (en) * 2013-03-25 2014-12-03 薛洪喜 Medicament for treating infertility of obstructive uterine tube
CN103156943A (en) * 2013-03-25 2013-06-19 薛洪喜 Medicament for treating infertility of obstructive uterine tube
CN103893340A (en) * 2014-03-26 2014-07-02 王景美 Traditional Chinese medicine preparation for treating cold coagulation and blood stasis type oviduct obstructive infertility
CN103893654A (en) * 2014-03-30 2014-07-02 赵玉红 Traditional Chinese medicine external plaster for treating salpinx obstructive infertility and nursing method thereof
CN103893654B (en) * 2014-03-30 2016-08-17 张凤霞 A kind of external traditional Chinese medicinal application treating oviduct obstructive sterility and care method
CN103990076A (en) * 2014-06-04 2014-08-20 河北省中医药研究院 Traditional Chinese medicine composition for treating female infertility and preparation and preparation method of composition
CN103990076B (en) * 2014-06-04 2018-07-06 河北省中医药研究院 A kind of Chinese medicine composition for treating female infertility and its preparation and preparation method
CN110292620A (en) * 2018-03-23 2019-10-01 李同春 The method of the Chinese medicine composition and preparation for the treatment of cancer and application and treating cancer
CN111643638A (en) * 2020-07-02 2020-09-11 贾锐 A method for treating infertility by compound therapy of traditional Chinese medicine
CN115737771A (en) * 2022-12-19 2023-03-07 广东罗浮山国药股份有限公司 Traditional Chinese medicine composition for treating liver qi stagnation type salpingemphraxis
CN115737771B (en) * 2022-12-19 2024-02-06 广东罗浮山国药股份有限公司 Traditional Chinese medicine composition for treating liver qi stagnation type oviduct obstruction

Also Published As

Publication number Publication date
CN101569673B (en) 2011-03-23

Similar Documents

Publication Publication Date Title
CN101569673B (en) Chinese medicinal preparation for treating female sterility caused by salpingemphraxis
CN102526616B (en) Chinese medicinal herb pills for treating cholecystitis and gallstone
CN103585378A (en) A Chinese medicinal composition for treating female infertility, and its preparation method
CN101428106B (en) Medicament composition for treating female infertility, and uses thereof
CN106266463A (en) A kind of Chinese medicine composition for treating hyperuricemia and application thereof
CN103550709B (en) A kind of Chinese medicine for the treatment of chronic pelvic inflammatory disease
CN102973677B (en) Traditional Chinese medicine for treating ovarian cyst
CN102872300B (en) Traditional Chinese medicine for treating non-gonococcal urethritis
CN102895563B (en) Medicine for treating urinary retention after cesarean section
CN102198202B (en) Pills for treating gout
CN104069441A (en) Traditional Chinese medicine composition for treating urinary organs calculus
CN101301343B (en) Chinese medicine paste for promoting healing of bone fracture
CN101366878A (en) Traditional Chinese medicine for female acyesis and aphoria and preparation method thereof
CN106389557B (en) A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion
CN103845547A (en) Traditional Chinese medicine decoction for treating mumps
CN108671186A (en) A kind of Chinese medicinal enema for treating chronic pelvic inflammatory disease
CN102895564A (en) Chinese medicine for treating tubal nowhere and preparation method thereof
CN106421172A (en) Combinational traditional Chinese medicine for curing male infertility
CN106266970B (en) A kind of Chinese medicine composition treated production and cause endometritis
CN106138919A (en) A kind of Chinese medicine composition treating gastric cancer
CN105560994A (en) Traditional Chinese medicine composition for treating prolapse of uterus
CN105853782A (en) Traditional Chinese medicinal composition for treating uterine prolapsed
CN103800764A (en) Traditional Chinese medicine for treating chronic pelvic inflammatory disease
CN105148050A (en) Traditional Chinese medicinal composition for treating kidney stone
CN104971308A (en) Traditional Chinese medicine composition for treating chronic prostatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant